Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma.
Kristensen NP, Heeke C, Tvingsholm SA, Borch A, Draghi A, Crowther MD, Carri I, Munk KK, Holm JS, Bjerregaard AM, Bentzen AK, Marquard AM, Szallasi Z, McGranahan N, Andersen R, Nielsen M, Jönsson GB, Donia M, Svane IM, Hadrup SR.
Kristensen NP, et al. Among authors: svane im.
J Clin Invest. 2022 Jan 18;132(2):e150535. doi: 10.1172/JCI150535.
J Clin Invest. 2022.
PMID: 34813506
Free PMC article.
Clinical Trial.